(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

Adolescents and young adults with preexisting autoimmune disease are more likely to develop type 1 diabetes than those ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Ever since the initial essay on the rising incidence of kidney disease was published last week, there has been a deluge of emails, text messages, and ...

Managing blood sugar is less about drastic cuts and more about informed pairing and mindful swapping. By recognizing the ...

This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...

Originally for diabetes, drugs like Ozempic and Mounjaro are now popular for weight loss but experts warn of risks. These ...

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to the Company from the ...

Though the FDA banned partially hydrogenated oils from food production by 2020, these dangerous trans fats still lurk in many ...

A new poll finds that many Americans remain hesitant to buy electric vehicles. The AP-NORC/EPIC poll found only about 2 in 10 ...

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...